Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Roche
|
| gptkbp:acquisitionYear |
2005
|
| gptkbp:focusesOn |
glycoengineering
antibody therapeutics |
| gptkbp:foundedIn |
2000
|
| gptkbp:founder |
Prof. Andreas Plückthun
|
| gptkbp:headquartersLocation |
gptkb:Zurich,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Glycart Biotechnology
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:obinutuzumab
|
| gptkbp:parentCompany |
gptkb:Roche
|
| gptkbp:website |
https://www.glycart.com/
|
| gptkbp:bfsParent |
gptkb:Wellington_Partners
|
| gptkbp:bfsLayer |
7
|